Clinical Trial Update: A First-in-human Study to Learn How Safe BAY 3713372 is and How it Works in Participants With MTAP-deleted Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A first-in-human Phase 1/2 study is evaluating the safety, pharmacology, and mechanism of BAY 3713372 in participants with MTAP-deleted solid tumors and is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mtap-deleted Solid Tumors

Drugs mentioned

• BAY 3713372

Snippet

Sponsor: Bayer | Conditions: MTAP-deleted Solid Tumors | Phase 1, Phase 2 | Status: RECRUITING